Direct healthcare professional communication on a new contraindication for Adempas (riociguat) in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP)
04.07.2016
more
04.07.2016
more
30.06.2016
more
30.06.2016
more
10.06.2016
more
10.06.2016
more
03.06.2016
more
30.05.2016
more
18.05.2016
more
17.05.2016
more
09.05.2016
more